News

A2 Healthcare has been selected as a FINALIST in the “BEST CONTRACT RESEARCH ORGANIZATION” category at the “CITELINE JAPAN AWARDS 2025.”

The Citeline Japan Awards recognize excellence and innovation across Japan’s pharmaceutical and biotechnology sectors and underscore Japan’s pivotal role in the global healthcare market. Being named a finalist reflects recognition of our ongoing efforts and commitment to advancing clinical development.

Looking ahead, A2 Healthcare will continue to deliver value beyond the traditional CRO scope, helping to address drug lag and drug loss in Japan and bringing more innovative treatment opportunities to patients nationwide.